Business context and reporting period
This filing is a Form 10-Q for GSI Group Inc. (the registrant named in the filing), for the quarter ended July 3, 2015; it is not identified in the filing as Novanta Inc. GSI designs and sells photonics, vision technology, and precision motion products, primarily to OEMs in medical and advanced industrial markets. The company reported three segments: Laser Products, Vision Technologies, and Precision Motion.
Unless noted otherwise, financial amounts below are U.S. dollars. Statements of operations compare the three and six months ended July 3, 2015 with the corresponding periods ended June 27, 2014. Balance sheet comparisons are to December 31, 2014.
Financial performance and liquidity
| Metric | Three months | Six months |
|---|---|---|
| Revenue | $96.5 million, down 0.4% | $191.1 million, up 8.6% |
| Gross profit / margin | $41.3 million / 42.8% | $81.4 million / 42.6% |
| Operating income from continuing operations | $10.3 million, versus $6.5 million | $15.7 million, versus $10.5 million |
| Net income attributable to GSI | $19.5 million, versus $0.7 million | $22.9 million, versus $1.7 million |
| Diluted EPS from continuing operations | $0.56, versus $0.10 | $0.66, versus $0.18 |
| Cash from continuing operations | Not provided by quarter in the filing text | $14.6 million, versus $19.9 million |
Net income and EPS benefited substantially from the $19.6 million pre-tax gain on the JK Lasers sale; foreign-exchange transaction losses partly offset that benefit. For the quarter, the foreign-exchange loss was $3.2 million and net other income was $20.0 million. Six-month operating cash flow declined despite higher continuing-operations income, with working-capital changes among the factors affecting cash generation.
At July 3, cash and cash equivalents were $81.1 million, total current assets $212.6 million, and current liabilities $62.0 million. Debt totaled $116.3 million: $31.3 million term loans and $85.0 million revolving borrowings. The company had $90.0 million of unused revolving capacity; the facility matures in December 2017. Its leverage ratio was 1.94 against a maximum of 3.00, and fixed-charge coverage was 3.86 against a minimum of 1.50; the company reported covenant compliance. Cash increased from $51.1 million at year-end, including $47.5 million held by subsidiaries outside Canada and the United States.
Material changes versus the prior comparable period
- Organic revenue growth, excluding acquisitions, divestitures, and foreign-exchange effects, was 5.0% for the quarter and 6.3% for the half year. Foreign exchange reduced reported revenue growth by 4.6 and 5.0 percentage points, respectively.
- Quarterly segment revenue changed: Laser Products fell 3.7% to $42.2 million, Vision Technologies fell 10.3% to $31.2 million, and Precision Motion rose 26.3% to $23.1 million. Vision Technologies weakness reflected softer medical equipment spending; Precision Motion growth reflected Applimotion and stronger optical encoder sales.
- Gross margin rose from 39.9% to 42.8% for the quarter and from 40.2% to 42.6% for the half year. Laser Products and Precision Motion margins improved; Vision Technologies’ quarterly margin declined partly due to warranty costs on a medical printer.
- Operating income improved in both periods, while six-month operating expenses rose to $65.6 million from $60.2 million, including higher R&D and restructuring/divestiture costs.
- On February 19, GSI acquired Applimotion for approximately $14.0 million, including $1.0 million estimated contingent consideration. On April 15, it sold JK Lasers for $30.6 million net cash proceeds; approximately $1.0 million of working-capital adjustment was estimated payable to the buyer.
Outlook, management commentary, risks, and unusual items
Management said operating cash flows were expected to cover operating and capital expenditure needs for at least the next 12 months, with the revolving facility as additional liquidity. The filing provides no quantified earnings or revenue guidance. The 2015 restructuring program was intended to remove redundant costs and redirect savings toward higher-growth businesses and lower-cost regions; $2.9 million of restructuring, acquisition, and divestiture-related costs was recorded in the first half.
Key risks cited include cyclical customer capital spending and economic conditions; foreign-currency exposure; acquisition integration and divestiture execution; product, supply-chain, and delivery issues; competition and innovation; indebtedness and access to subsidiary cash; and tax uncertainty. The company reported ordinary-course legal claims, stating it did not expect a material adverse effect, while noting no assurance. It reported no material changes to previously disclosed risk factors, and management concluded disclosure controls were effective.
Unusual items include the JK Lasers disposal gain and related foreign-exchange losses, the Applimotion acquisition and contingent consideration, and discontinued-operation losses of $13,000 in 2015 versus $2.7 million for the prior-year quarter. The India joint venture was deconsolidated following an agreement to sell the company’s 50% interest.
Important facts for investors to verify
- Confirm the issuer identity: the supplied filing names GSI Group Inc., although the request metadata names Novanta Inc.
- Assess earnings excluding the JK Lasers gain, related currency losses, and other acquisition/divestiture and restructuring effects.
- Review the drivers and sustainability of organic growth, especially the Vision Technologies decline and Precision Motion acquisition-led growth.
- Monitor operating cash conversion, working capital, debt levels, covenant headroom, and the location and availability of cash held abroad.
- Track the JK Lasers working-capital settlement, Applimotion contingent-payment targets, and restructuring execution and costs.